|
Volumn 100, Issue 9, 1993, Pages 832-838
|
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiol
a b c |
Author keywords
[No Author keywords available]
|
Indexed keywords
DESOGESTREL;
DESOGESTREL PLUS ETHINYLESTRADIOL;
DESOLETT;
ETHINYLESTRADIOL;
ORAL CONTRACEPTIVE AGENT;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
NORMAL HUMAN;
ORAL CONTRACEPTION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SPOTTING;
AMENORRHEA;
BIOLOGY;
BLEEDING;
BLOOD PRESSURE;
BODY WEIGHT;
COMPARATIVE STUDIES;
CONTRACEPTION;
CONTRACEPTION FAILURE;
CONTRACEPTIVE AGENTS;
CONTRACEPTIVE AGENTS, ESTROGEN;
CONTRACEPTIVE AGENTS, FEMALE;
CONTRACEPTIVE AGENTS, PROGESTIN;
CONTRACEPTIVE METHOD SWITCHING;
CONTRACEPTIVE METHODS--ADMINISTRACTION AND DOSAGE;
CONTRACEPTIVE METHODS--SIDE EFFECTS;
CONTRACEPTIVE USAGE;
DENMARK;
DESOGESTREL;
DEVELOPED COUNTRIES;
DISEASES;
DIZZINESS;
DOUBLE-BLIND STUDIES;
ETHINYL ESTRADIOL;
EUROPE;
FAMILY PLANNING;
HEADACHE;
HEMIC SYSTEM;
HEMOGLOBIN LEVEL;
MENORRHAGIA;
MENSTRUATION DISORDERS;
METHOD ACCEPTABILITY;
METRORRHAGIA;
NORTHERN EUROPE;
NORWAY;
ORAL CONTRACEPTIVES, LOW-DOSE--ADMINISTRACTION AND DOSAGE;
ORAL CONTRACEPTIVES, LOW-DOSE--SIDE EFFECTS;
ORAL CONTRACEPTIVES--ADMINISTRACTION AND DOSAGE;
ORAL CONTRACEPTIVES--SIDE EFFECTS;
PHYSIOLOGY;
RESEARCH METHODOLOGY;
RESEARCH REPORT;
SCANDINAVIA;
SIGNS AND SYMPTOMS;
STUDIES;
SWEDEN;
ADOLESCENT;
ADULT;
BODY WEIGHT;
CHEMISTRY, PHARMACEUTICAL;
CONTRACEPTIVES, ORAL, COMBINED;
DESOGESTREL;
DOUBLE-BLIND METHOD;
ETHINYL ESTRADIOL;
FEMALE;
HUMAN;
MENSTRUAL CYCLE;
PANCURONIUM;
RISK FACTORS;
|
EID: 0027282228
PISSN: 14700328
EISSN: 14710528
Source Type: Journal
DOI: 10.1111/j.1471-0528.1993.tb14309.x Document Type: Article |
Times cited : (86)
|
References (24)
|